Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
-1.78M | 546.00K | -7.05M | 850.00K | 10.22M | 1.21M | Gross Profit |
-8.16M | 546.00K | -7.05M | 850.00K | 10.22M | 1.21M | EBIT |
-1.43M | -1.37M | -9.23M | -1.75M | 8.66M | 88.00K | EBITDA |
-671.00K | 0.00 | -9.37M | -1.74M | 8.66M | 98.00K | Net Income Common Stockholders |
-4.69M | -2.73M | -9.91M | -3.54M | 8.66M | 88.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
695.22K | 5.89M | 495.00K | 1.21M | 3.53M | 5.56M | Total Assets |
11.36M | 7.46M | 8.25M | 16.62M | 17.69M | 9.08M | Total Debt |
0.00 | 0.00 | 127.00K | 260.00K | 351.00K | 438.00K | Net Debt |
-695.22K | -5.89M | -368.00K | -947.00K | -3.18M | -5.12M | Total Liabilities |
4.18M | 3.35M | 2.92M | 1.63M | 1.04M | 1.06M | Stockholders Equity |
7.18M | 3.95M | 5.33M | 14.99M | 16.65M | 8.03M |
Cash Flow | Free Cash Flow | ||||
-1.15M | -1.23M | -1.26M | -829.00K | -256.00K | -280.00K | Operating Cash Flow |
-1.15M | -1.23M | -1.26M | -829.00K | -253.00K | -266.00K | Investing Cash Flow |
-2.52M | 780.00K | -105.00K | -661.00K | -1.80M | 110.00K | Financing Cash Flow |
694.00K | 2.60M | 1.18M | 0.00 | -1.00K | -384.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $11.85B | 9.13 | 8.11% | 79.54% | 12.80% | -5.24% | |
52 Neutral | $15.11M | 165.15 | -0.60% | 7.68% | 13.39% | -107.74% | |
49 Neutral | $7.36M | 0.31 | -291.99% | ― | -18.97% | ― | |
45 Neutral | $10.72M | ― | -58.75% | ― | ― | 73.32% | |
34 Underperform | $14.66M | ― | -422.39% | ― | ― | -20.33% |
On February 26, 2025, Oxbridge Re Holdings Limited announced that its subsidiary, SurancePlus Inc., commenced an offering of digital token-based Participation Shares under a 3-year Participation Share Investment Contract. The proceeds from this offering will be used to purchase participating notes of Oxbridge Re NS, which will be invested in collateralized reinsurance contracts. The offering is exempt from registration under the Securities Act and targets accredited investors in the U.S. and non-U.S. persons under Regulation S.